291 related articles for article (PubMed ID: 31123087)
1. Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.
Hughes RM; Simons BW; Khan H; Miller R; Kugler V; Torquato S; Theodros D; Haffner MC; Lotan T; Huang J; Davicioni E; An SS; Riddle RC; Thorek DLJ; Garraway IP; Fertig EJ; Isaacs JT; Brennen WN; Park BH; Hurley PJ
Cancer Res; 2019 Jul; 79(14):3636-3650. PubMed ID: 31123087
[TBL] [Abstract][Full Text] [Related]
2. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
3. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer.
Hurley PJ; Sundi D; Shinder B; Simons BW; Hughes RM; Miller RM; Benzon B; Faraj SF; Netto GJ; Vergara IA; Erho N; Davicioni E; Karnes RJ; Yan G; Ewing C; Isaacs SD; Berman DM; Rider JR; Jordahl KM; Mucci LA; Huang J; An SS; Park BH; Isaacs WB; Marchionni L; Ross AE; Schaeffer EM
Clin Cancer Res; 2016 Jan; 22(2):448-58. PubMed ID: 26446945
[TBL] [Abstract][Full Text] [Related]
4. Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.
Sung SY; Liao CH; Wu HP; Hsiao WC; Wu IH; Jinpu ; Yu ; Lin SH; Hsieh CL
PLoS One; 2013; 8(8):e71637. PubMed ID: 23977098
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of glypican-1 expression induces an activated fibroblast phenotype in a human bone marrow-derived stromal cell-line.
Kaur SP; Verma A; Lee HK; Barnett LM; Somanath PR; Cummings BS
Sci Rep; 2021 Apr; 11(1):9262. PubMed ID: 33927256
[TBL] [Abstract][Full Text] [Related]
6. Expression of asporin reprograms cancer cells to acquire resistance to oxidative stress.
Sasaki Y; Takagane K; Konno T; Itoh G; Kuriyama S; Yanagihara K; Yashiro M; Yamada S; Murakami S; Tanaka M
Cancer Sci; 2021 Mar; 112(3):1251-1261. PubMed ID: 33393151
[TBL] [Abstract][Full Text] [Related]
7. Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures.
Brennen WN; Kisteman LN; Isaacs JT
Prostate; 2016 May; 76(6):552-64. PubMed ID: 26732992
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1.
Barcellos-de-Souza P; Comito G; Pons-Segura C; Taddei ML; Gori V; Becherucci V; Bambi F; Margheri F; Laurenzana A; Del Rosso M; Chiarugi P
Stem Cells; 2016 Oct; 34(10):2536-2547. PubMed ID: 27300750
[TBL] [Abstract][Full Text] [Related]
9. Roles of cell fusion between mesenchymal stromal/stem cells and malignant cells in tumor growth and metastasis.
Zhang LN; Zhang DD; Yang L; Gu YX; Zuo QP; Wang HY; Xu J; Liu DX
FEBS J; 2021 Mar; 288(5):1447-1456. PubMed ID: 33070450
[TBL] [Abstract][Full Text] [Related]
10. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment.
Spaeth EL; Labaff AM; Toole BP; Klopp A; Andreeff M; Marini FC
Cancer Res; 2013 Sep; 73(17):5347-59. PubMed ID: 23838935
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?
Krueger TE; Thorek DLJ; Meeker AK; Isaacs JT; Brennen WN
Prostate; 2019 Feb; 79(3):320-330. PubMed ID: 30488530
[TBL] [Abstract][Full Text] [Related]
13. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract][Full Text] [Related]
14. Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.
Hurley PJ; Hughes RM; Simons BW; Huang J; Miller RM; Shinder B; Haffner MC; Esopi D; Kimura Y; Jabbari J; Ross AE; Erho N; Vergara IA; Faraj SF; Davicioni E; Netto GJ; Yegnasubramanian S; An SS; Schaeffer EM
Cancer Res; 2015 Oct; 75(20):4322-34. PubMed ID: 26294211
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem/Stromal Cell Engulfment Reveals Metastatic Advantage in Breast Cancer.
Chen YC; Gonzalez ME; Burman B; Zhao X; Anwar T; Tran M; Medhora N; Hiziroglu AB; Lee W; Cheng YH; Choi Y; Yoon E; Kleer CG
Cell Rep; 2019 Jun; 27(13):3916-3926.e5. PubMed ID: 31242423
[TBL] [Abstract][Full Text] [Related]
16. Asporin participates in gastric cancer cell growth and migration by influencing EGF receptor signaling.
Ding Q; Zhang M; Liu C
Oncol Rep; 2015 Apr; 33(4):1783-90. PubMed ID: 25673058
[TBL] [Abstract][Full Text] [Related]
17. Asporin Expression on Stromal Cells and/or Cancer Cells Might Be A Useful Prognostic Marker in Patients with Diffuse-Type Gastric Cancer.
Yashiro M; Hasegawa T; Yamamoto Y; Tsujio G; Nishimura S; Sera T; Sugimoto A; Kushiyama S; Kasashima H; Fukuoka T; Sakurai K; Toyokawa T; Kubo N; Ohira M
Eur Surg Res; 2021; 62(1):53-60. PubMed ID: 33882483
[TBL] [Abstract][Full Text] [Related]
18. Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells.
Borghese C; Casagrande N; Pivetta E; Colombatti A; Boccellino M; Amler E; Normanno N; Caraglia M; De Rosa G; Aldinucci D
Oncotarget; 2017 Jun; 8(26):42926-42938. PubMed ID: 28477013
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.
Gonzalez ME; Martin EE; Anwar T; Arellano-Garcia C; Medhora N; Lama A; Chen YC; Tanager KS; Yoon E; Kidwell KM; Ge C; Franceschi RT; Kleer CG
Cell Rep; 2017 Jan; 18(5):1215-1228. PubMed ID: 28147276
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect.
Wang ML; Pan CM; Chiou SH; Chen WH; Chang HY; Lee OK; Hsu HS; Wu CW
Cancer Res; 2012 Nov; 72(22):6051-64. PubMed ID: 23139208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
